• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: collagen proportionate area as a prognostic indicator in NAFLD-authors' reply.

作者信息

Buzzetti Elena, Tsochatzis Emmanuel A

机构信息

UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.

出版信息

Aliment Pharmacol Ther. 2019 Jun;49(11):1454-1455. doi: 10.1111/apt.15271.

DOI:10.1111/apt.15271
PMID:31074896
Abstract
摘要

相似文献

1
Editorial: collagen proportionate area as a prognostic indicator in NAFLD-authors' reply.社论：胶原比例面积作为非酒精性脂肪性肝病的预后指标——作者回复
Aliment Pharmacol Ther. 2019 Jun;49(11):1454-1455. doi: 10.1111/apt.15271.
2
Editorial: collagen proportionate area as a prognostic indicator in NAFLD.
Aliment Pharmacol Ther. 2019 Jun;49(11):1452-1454. doi: 10.1111/apt.15249.
3
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply.信函：使用胶原比例面积来量化肝纤维化并预测非酒精性脂肪性肝病的临床结局——作者回复
Aliment Pharmacol Ther. 2019 Aug;50(3):339. doi: 10.1111/apt.15385.
4
Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Authors' reply.社论：亚洲的非酒精性脂肪性肝病——与晚期疾病的临床关联日益明晰。作者回复。
Aliment Pharmacol Ther. 2018 Apr;47(7):1037-1038. doi: 10.1111/apt.14572.
5
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.编者按：非酒精性脂肪性肝病患者F3和F4的逐步风险分层——作者回复
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.
6
Editorial: NAFLD in HIV infection--call for action. Authors' reply.社论：HIV感染中的非酒精性脂肪性肝病——呼吁采取行动。作者回复。
Aliment Pharmacol Ther. 2015 Mar;41(6):591. doi: 10.1111/apt.13087.
7
Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD - authors' reply.社论：使用先进磁共振成像技术监测非酒精性脂肪性肝病的更多证据——作者回复
Aliment Pharmacol Ther. 2017 May;45(9):1271-1272. doi: 10.1111/apt.14037.
8
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? Authors' reply.社论：基于尿液的代谢组学能否改善非酒精性脂肪性肝病晚期纤维化的诊断？作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(11):1205-1206. doi: 10.1111/apt.15756.
9
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.社论：非酒精性脂肪性肝病（NAFLD）的临床结局——细节决定成败。作者回复。
Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.
10
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity-authors' reply.社论：非酒精性脂肪性肝病和肥胖患者的肝移植——作者回复
Aliment Pharmacol Ther. 2017 Aug;46(4):460-461. doi: 10.1111/apt.14195.